EDESA BIOTECH, INC. Income (Loss) from Equity Method Investments
EDESA BIOTECH, INC. (EDSA) reported Income (Loss) from Equity Method Investments of -$46.46 thousand for the 6-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2019-05-08
- EDESA BIOTECH, INC. income (loss) from equity method investments for the quarter ending 2019-03-31 was $0.00.
- EDESA BIOTECH, INC. income (loss) from equity method investments for the quarter ending 2018-12-31 was -$46.46K.
- EDESA BIOTECH, INC. income (loss) from equity method investments for the quarter ending 2018-03-31 was $0.00.
- EDESA BIOTECH, INC. income (loss) from equity method investments for the quarter ending 2017-12-31 was $0.00.
- EDESA BIOTECH, INC. income (loss) from equity method investments for fiscal 2018 was -$20.24K.
- EDESA BIOTECH, INC. income (loss) from equity method investments for fiscal 2017 was $0.00.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|
| 2019-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | -$46.46K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | -$46.46K 10-Q · filed 2019-02-05 | ||
| 2018-09-30 | -$20.24K 10-K · filed 2018-11-30 | ||
| 2018-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | $0.00 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $0.00 10-Q · filed 2019-02-05 | ||
| 2017-09-30 | $0.00 10-K · filed 2018-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |